Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition) ›› 2025, Vol. 11 ›› Issue (02): 204-209. doi: 10.3877/cma.j.issn.2096-1537.2025.02.019

• Review • Previous Articles    

Research progress in mtDNA in lung injury of ARDS patients

Lili Huang1, Yi Yang1, Haibo Qiu1,()   

  1. 1. Department of Critical Care Medicine,Jiangsu Provincial Key Laboratory of Critical Care Medicine,Zhongda Hospital,School of Medicine,Southeast University,Nanjing 210009,China
  • Received:2023-11-13 Online:2025-05-28 Published:2025-07-18
  • Contact: Haibo Qiu

Abstract:

Acute respiratory distress syndrome (ARDS) is a common respiratory critical syndrome and one of the main causes of death in critically ill patients.It has been a hot and difficult point in respiratory and critical care medicine for many years.More and more studies have found that mitochondrial DNA (mtDNA)levels are associated with the development of ARDS.Plasma mtDNA levels are expected to be biomarkers for clinical diagnosis and evaluation of ARDS lung injury severity.In this review,we elaborate on the release and production of mtDNA and the underlying mechanisms leading to ARDS injury,prospecting for new therapies for ARDS targeting mtDNA.

Key words: Mitochondrial DNA, Acute respiratory distress syndrome, Lung injury

京ICP 备07035254号-19
Copyright © Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), All Rights Reserved.
Tel: 010-51322627 E-mail: ccm@cma.org.cn
Powered by Beijing Magtech Co. Ltd